Lab-grown ‘mini-stomachs’ could shed light on children’s COVID symptoms
A ‘lab-grown model’ of the human stomach, that can be used to study how infections affect the gastrointestinal system, has been developed for the first time.
A UCL-led team of international scientists have built on...
A first launch on OTC drugs with Advancia®!
After the successful launch of Nemera’s next generation nasal spray pump within its Crimp-on version, Advancia® Snap-on version is now on the South Korean market with an intranasal decongestant nasal spray.
JW Pharmaceutical has recently...
FUJIFILM Diosynth Biotechnologies Enters Strategic Partnership With OXGENE™ To Address Supply Bottlenecks In Gene...
Capabilities expand to supplying plasmids for triple transfections
BILLINGHAM, United Kingdom, April 23, 2020 /PRNewswire/ -- FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in the biopharmaceutical industry with the...
UCLB spinout Freeline Closes $120 Million Series C Financing Round
Freeline, a biotechnology company focused on developing curative gene therapies for chronic systemic diseases, today announced the closing of a $120 million extended Series C financing. The financing augments Syncona’s previously announced Series C investment in Freeline of $40 million (£30.6 million) with an additional...
Study throws light on the way badly injured victims are taken to hospital
A study from the Perelman School of Medicine at the University of Pennsylvania in America found no significant difference in survival rates between gunshot and stabbing victims in Philadelphia whether they were transported to...
Advances in longitudinal RWD and genomics access for drug development in Africa
A new partnership aims to build the largest integrated clinical and genomics data biobank in Africa, representing a major boost for RWD research across the continent.
The collaboration is between BC Platforms (BCP), a global...
Scientists excited about cancer research findings
Scientists from Weill Cornell Medical College in New York, working with not-for-profit health organisation Houston Methodist, have cast new light on a deadly form of breast cancer.
The team have found that a gene not...
Cryopreservation Excipient for Cell Therapies
AMSBIO has launched STEM-CELLBANKER® EX - a next generation cryopreservation product that eliminates the need for the traditional washing steps required in cell therapy product development.
Rapid developments in cell, tissue, and gene therapies over...
UCLB and Apollo Therapeutics secure first out-licensing deal to Deerfield, a leading U.S....
London, and New York, NY, 21 July 2020 – UCL Business (UCLB) and Apollo Therapeutics (Apollo), a pioneering collaboration between three global pharmaceutical companies and three UK university technology transfer offices, along with Deerfield Management Company,...
Changes in the eye connected to a decline in memory
Researchers in the US have found that changes in the blood vessels of the eye are associated with a greater decline in people’s memory and language skills over a 20-year period. Their findings were...
Superworms have the munchies for polystyrene
A species of worm with an appetite for polystyrene could be the key to plastic recycling on a mass scale.
Researchers at the University of Queensland have discovered the common Zophobas morio ‘superworm’ can eat through polystyrene,...
Novel mechanism links IBD genetic defect to gut leakiness
A study into ‘leaky gut’ is the first to show how a disease mutation increases the risk of developing Inflammatory Bowel Disease (IBD).
Researchers led by a biomedical scientist at the University of California, Riverside,...
AI could improve diagnosis for over 100,000 prostate patients in UK
The use of AI to identify prostate cancer is currently being validated in the first retrospective study of its kind in the UK.
Real-world data from hospitals and scanner types is being scrutinised, to show...
Hyperactive FOXA1 reprograms endocrine-resistant breast cancer to become metastatic
A team led by researchers at Baylor College of Medicine and Harvard Medical School has unveiled a novel mechanism that helps explain how endocrine-resistant breast cancer acquires metastatic behavior, opening the possibility of new...
IBM releases novel AI-powered technology to accelerate medical research for COVID-19
IBM has today released a new set of cloud- and AI-powered technologies to help researchers, doctors and scientists accelerate COVID-19 drug discovery.
These novel resources, from across IBM and available beginning today (Friday 3 April)...
Antimicrobial resistance ‘arms race’ heats up
An advanced interventional microbiomics company, which is developing non-antibiotic methods for the control of multiple-drug resistant superbugs and other infectious disease, is stepping up development of a cure for antibiotic resistant bacteria.
BioPlx has set...